Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Vertex Pharm

Article Abstract:

Vertex Pharmaceuticals, Inc. uses drug discovery technologies to treat medical problems like cancer. A comparative analysis of the company sales and financial details of from 1991 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Ferrara, J. Susan
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, Company sales and earnings, Company earnings/profit

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Vertex Pharm, Inc

Article Abstract:

The price appreciation potential of Vertex Pharmaceuticals, Inc. for the years 2010-2012 is discussed. The Cambridge, Massachusetts- based company develops small molecule drugs for various diseases.

Author: Ferrara, J. Susan
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Evaluation, Stocks, Stock prices

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry, Securities, Company securities, Vertex Pharmaceuticals Inc.
Similar abstracts:
  • Abstracts: ISIS Pharm., Inc. Vertex Pharmaceuticals Inc
  • Abstracts: NPS Pharm., Inc. Pharma Product Development Inc
  • Abstracts: Regeneron Pharm. Newmont Mining Corp. Regeneron Pharmaceuticals Inc
  • Abstracts: Techne Corp. Medarex Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.